Eligibility criteria | |
Study I | 1. Patients who were 18 to 80Â years of age. |
2. Patients meet the criteria for sepsis which defined by the surviving sepsis campaign. | |
2.1 Patients had a documented or suspected infection | |
2.2 Patients had some of the following conditions: | |
2.2.1 Fever (>38.3 °C) or Hypothermia (<36 °C) | |
2.2.2 Heart rate >90 beats/min; | |
2.2.3 White blood cell count >12 × 109/L or <4 × 109/L | |
2.2.4 Tachypnea | |
2.2.5 Altered mental status | |
2.2.6 Significant edema or positive fluid balance (>20Â mL/kg/24Â h) | |
2.2.7 Plasma procalcitonin more than two SD above the normal value | |
2.2.8 Arterial hypoxemia (PaO2/FiO2 <300) | |
2.2.9 Creatinine increase >44.2 μmol/L | |
2.2.10 Arterial hypotension (SBP <90Â mmHg, MAP <70Â mmHg) | |
2.2.11 Coagulation abnormalities (INR >1.5 or APTT >60Â s) | |
2.2.12 Thrombocytopenia (platelet count <100 × 109/L) | |
2.2.13 Hyperbilirubinemia (plasma total bilirubin >70Â mmol/L) | |
2.2.14 Hyperlactatemia (>1Â mmol/L) | |
2.2.15 Decreased capillary refill or mottling | |
3. Patients whose platelet counts were under 100 × 109/L. | |
Study II | 1. Patients whose platelet counts were under 50 × 109/L. |
2. Patients meet the criteria for severe sepsis which defined by the surviving sepsis campaign. | |
2.1 Patients had sepsis-induced tissue hypoperfusion or organ dysfunctionn (any of the following thought to be due to the infection) | |
2.1.1 Sepsis-induced hypotension | |
2.1.2 Hyperlactatemia (>2Â mmol/L) | |
2.1.3 Urine output <0.5Â mL/kg/h for more than 2Â h despite adequate fluid resuscitation | |
2.1.4 Acute lung injury with PaO2/FiO2 <250 | |
2.1.5 Creatinine >2.0Â mg/dL (176.8 mol/L) | |
2.1.6 Bilirubin >2Â mg/dL (34.2 mol/L) | |
2.1.7 Coagulation abnormalities (INR >1.5) | |
2.1.8 Thrombocytopenia (platelet count <100 × 109/L) | |
Exclusion criteria | |
 1. Patients with malignancies or bone marrow stem cell disorders within the last 2 years | |
 2. Patients who received chemotherapy or immunosuppressive agents within 6 months | |
 3. Patients who had a history of ITP or such autoimmune diseases | |
 4. Patients after cardiopulmonary resuscitation (CPR) | |
 5. Patients who are less than 18 years or more than 85 years of age | |
 6. Pregnant or puerperal patients | |
 7. Patients having acute gastrointestinal hemorrhage | |
 9. Patients who have a history of bone marrow, lung, liver, kidney, or small bowel transplantation | |
 10. Patients with end-stage hepatic or renal failure | |
 11. Patients with disseminated intravascular coagulation (DIC) | |
 12. Patients with drug (antibiotics or heparin)-associated thrombocytopenia | |
 13. Gut failure or strict nil by mouth following surgery |